Kim, Yoon Tae Huh, Jin Won Choi, Yun Hui Yoon, Hee Kyeong Nguyen, Tram T. T. Chun, Eunho Jeong, Geunyeol Park, Sunyoung Ahn, Sungwoo Lee, Won-Kyu Noh, Young-Woock Lee, Kyoung Sun Ahn, Hee-Sung Lee, Cheolju Lee, Sang Min Kim, Kyung Su Suh, Gil Joon Jeon, Kyeongman Kim, Sunghoon Jin, Mirim 2024-06-28T08:00:40Z 2024-06-28T08:00:40Z 2024-06-28 2024-03 1757-4676 https://pubs.kist.re.kr/handle/201004/150153 The Acknowledgements section is corrected from: This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) of the Korean government (MSIT), Republic of Korea, grant numbers NRF-2019M3E5D5064771, the Korea Health Technology R&D Project by the Korea Health Industry Development Institute (KHIDI) of the Ministry of Health & Welfare, Republic of Korea, grant number HI20C0015, and HI122C10883, Daegu-Gyeongbuk/Osong Medical Cluster R&D Project funded by the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, Republic of Korea, grant number HI19C0763, and Korea Drug Development Fund funded by Ministry of Science and ICT, Ministry of Trade, Industry, and Energy, and Ministry of Health and Welfare, Republic of Korea, grant number RS-2022-00166575. To (see changes in bold) This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) of the Korean government (MSIT), Republic of Korea, grant numbers NRF-2019M3E5D5064771, the Korea Health Technology R&D Project by the Korea Health Industry Development Institute (KHIDI) of the Ministry of Health & Welfare, Republic of Korea, grant number HI20C0015, and HI22C1883, Daegu-Gyeongbuk/Osong Medical Cluster R&D Project funded by the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, Republic of Korea, grant number HI19C0763, and Korea Drug Development Fund funded by Ministry of Science and ICT, Ministry of Trade, Industry, and Energy, and Ministry of Health and Welfare, Republic of Korea, grant number RS-2022-00166575. This change does not affect the text or interpretation of the article. English John Wiley & Sons Ltd. Highly secreted tryptophanyl tRNA synthetase 1 as a potential theranostic target for hypercytokinemic severe sepsis (vol 16, pg 40, 2023) Article 10.1038/s44321-024-00030-4 1 EMBO Molecular Medicine, v.16, no.3, pp.665 - 665 EMBO Molecular Medicine 16 3 665 665 Y scie scopus 001220484700012 2-s2.0-85185322675 Medicine, Research & Experimental Research & Experimental Medicine Correction